24 HR ruxolitinib 33 MG Extended Release Oral Tablet [Jakafi]

This is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.

What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.

Inspect the RxNorm source identifier

These are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.